Eupraxia Pharmaceuticals Inc.
EPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001581178
No open-market purchases or sales by Eupraxia Pharmaceuticals Inc. insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $163.6M in total; no superinvestor holds it.
Superinvestors holding EPRX, Q2 2026
No superinvestor reported holding EPRX in Q2 2026.